Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Oct 15, 2022; 14(10): 2048-2060
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.2048
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.2048
Characteristic | Result |
Age diagnosis (yr) | 55.85 ± 13.26 |
Gender (%) | |
Male | 93 (61.6) |
Female | 58 (38.4) |
Distance to anal verge (cm) (%) | 4.91 ± 2.04 |
> 6 | 45 (29.8) |
≤ 6 | 106 (70.2) |
Pre-CEA (%) | |
Normal range | 98 (64.9) |
Elevated | 53 (35.1) |
Pre-T (%) | |
T1 | 2 (1.3) |
T2 | 10 (6.6) |
T3 | 133 (88.1) |
T4 | 6 (4.0) |
Pre-N (%) | |
N0 | 38 (25.2) |
N+ | 113 (74.8) |
Post-T (%) | |
pT0 | 7 (4.6) |
pT1 | 6 (4.0) |
pT2 | 48 (31.8) |
pT3 | 84 (55.6) |
pT4 | 4 (4.0) |
Post-N (%) | |
pN0 | 89 (58.9) |
pN+ | 62 (41.1) |
Tumor regression grade (%) | |
Grade 0 | 9 (6.3) |
Grade 1 | 34 (23.9) |
Grade 2 | 42 (29.6) |
Grade 3 | 57 (40.1) |
HER2 (%) | |
- | 124 (82.1) |
+ | 27 (17.9) |
LVI (%) | |
+ | 20 (13.2) |
- | 131 (86.8) |
Median follow-up period | 134 |
Distant metastasis, number (%) | |
Yes | 60 (39.7) |
No | 91 (60.3) |
Local recurrence, number (%) | |
Yes | 24 (15.9) |
No | 127 (84.1) |
- Citation: Chen N, Li CL, Peng YF, Yao YF. Long-term follow-up of HER2 overexpression in patients with rectal cancer after preoperative radiotherapy: A prospective cohort study. World J Gastrointest Oncol 2022; 14(10): 2048-2060
- URL: https://www.wjgnet.com/1948-5204/full/v14/i10/2048.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i10.2048